Home/Filings/4/0000914190-20-000393
4//SEC Filing

Bove Mauro 4

Accession 0000914190-20-000393

CIK 0000707511other

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 5:15 PM ET

Size

22.3 KB

Accession

0000914190-20-000393

Insider Transaction Report

Form 4
Period: 2020-10-15
Bove Mauro
Director
Transactions
  • Purchase

    Convertible Promissory Note (right to buy)

    2020-10-15$10000.00/sh
    Exercise: $0.36From: 2020-10-15Exp: 2025-10-15Common Stock (27,840 underlying)
  • Purchase

    Common Stock Warrant (right to buy)

    2020-10-15+20,88020,880 total
    Exercise: $0.45From: 2021-04-15Exp: 2025-10-15Common Stock (20,880 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $0.21Exp: 2021-03-25Common Stock (150,000 underlying)
    150,000
  • Stock Option (right to buy)

    Exercise: $0.36Exp: 2022-06-30Common Stock (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    Exercise: $0.28Exp: 2027-09-01Common Stock (125,000 underlying)
    125,000
  • Convertible Promissory Note (right to buy)

    Exercise: $0.12From: 2019-02-27Exp: 2024-02-27Common Stock (41,667 underlying)
  • Common Stock Warrant (right to buy)

    Exercise: $0.18From: 2019-08-27Exp: 2024-02-27Common Stock (31,250 underlying)
    31,250
  • Stock Option (right to buy)

    Exercise: $0.19Exp: 2022-02-11Common Stock (100,000 underlying)
    100,000
  • Stock Option (right to buy)

    Exercise: $0.21Exp: 2029-05-15Common Stock (200,000 underlying)
    200,000
  • Stock Option (right to buy)

    Exercise: $0.64Exp: 2023-03-16Common Stock (100,000 underlying)
    100,000
  • Common Stock Warrant (right to buy)

    Exercise: $0.18From: 2019-11-13Exp: 2024-05-13Common Stock (31,250 underlying)
    31,250
  • Stock Option (right to buy)

    Exercise: $0.21Exp: 2028-07-17Common Stock (200,000 underlying)
    200,000
  • Stock Option (right to buy)

    Exercise: $0.30Exp: 2030-06-10Common Stock (200,000 underlying)
    200,000
  • Convertible Promissory Note (right to buy)

    Exercise: $0.12From: 2019-05-13Exp: 2024-05-13Common Stock (41,667 underlying)
Footnotes (4)
  • [F1]100% vested.
  • [F2]50,000 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
  • [F3]50,000 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
  • [F4]50,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.

Issuer

REGENERX BIOPHARMACEUTICALS INC

CIK 0000707511

Entity typeother

Related Parties

1
  • filerCIK 0001396271

Filing Metadata

Form type
4
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 5:15 PM ET
Size
22.3 KB